Related Experiment Video
Updated: Jan 17, 2026

09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.4K
Systemic Lupus Erythematosus in Pregnancy.
Angeliki Gerede1, Efthymios Oikonomou1, Sofoklis Stavros2
1Department of Obstetrics and Gynecology, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
Medical Sciences (Basel, Switzerland)
|September 22, 2025
Summary
Systemic Lupus Erythematosus (SLE) and pregnancy remain complex, with risks for both mother and child. Further research is needed to understand SLE
Area of Science:
- Rheumatology
- Obstetrics
- Perinatology
Background:
- The relationship between Systemic Lupus Erythematosus (SLE) and pregnancy is not fully understood.
- Existing research presents conflicting findings on SLE's impact on pregnancy and vice versa.
- Pregnancy in women with SLE poses potential risks, affecting childbearing-aged individuals.
Purpose of the Study:
- To systematically review the literature on the reciprocal relationship between SLE and pregnancy.
- To assess whether SLE increases the likelihood of pregnancy complications.
- To determine if pregnancy influences the progression of SLE.
Main Methods:
- A comprehensive search of original research articles was performed.
- Online databases including PubMed and Google Scholar were utilized.
- An initial pool of 877 studies was narrowed down to 65 for detailed analysis.
Main Results:
- 65 relevant articles were selected for in-depth review after initial screening.
- Analysis focused on understanding the complex interactions between SLE and pregnancy outcomes.
Conclusions:
- Despite advances in SLE management, its interaction with pregnancy requires more research.
- Pregnancies in women with SLE carry inherent risks.
- Multidisciplinary monitoring and personalized treatments are crucial for optimizing maternal and fetal outcomes.
Related Concept Videos
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Rh Blood Group
2.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.8K

